✦ LIBER ✦

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

✍ Scribed by Djelila Allouache; Sulochana R Gawande; Michele Tubiana-Hulin; Nicole Tubiana-Mathieu; Sophie Piperno-Neumann; Fawzia Mefti; Laurence Bozec; Jean-Yves Genot

Book ID: 115010664
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 275 KB
Volume: 5
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-5-151

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Weekly Docetaxel/Gemci

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB

Phase II Study of Gemcitabine and Bevaci

Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer

✍ Rachel Borson; Graydon Harker; James Reeves; Thaddeus Beck; Steven Hager; Willia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 387 KB

Gemcitabine and split-dose paclitaxel or

Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study

✍ Kei Siong Khoo; Syed Hasan Manzoor Zaidi; Vichien Srimuninnimit; Santai Song; Re 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A Randomized Phase II Study of Paclitaxe

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

✍ Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nad 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 441 KB

Biweekly gemcitabine–paclitaxel, gemcita

Biweekly gemcitabine–paclitaxel, gemcitabine–carboplatin, or gemcitabine–cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial

✍ Binghe Xu; Zefei Jiang; Sung-Bae Kim; Shiying Yu; Jifeng Feng; Artur Malzyner; A 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 289 KB

Bevacizumab plus gemcitabine and oxalipl

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB